Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Once LABS is associated with the name of their global pharma

<< Previous

Bullboard Posts

Next >>

Comment by subaru1ion Sep 08, 2023 11:08am

81 Views

Post# 35626131

RE:RE:Once LABS is associated with the name of their global pharma

Pidduck did mention disclosure in Q4 of their South American pharma customer once they receive their ANIVSA new drug approval, an established top tier generic drug maker in Brazil. One of them in Brazil is 40% owned by Pfizer as well but is it the one LABS is dealing with?

We are a publicly traded company so anything could happen imho, even a hostile take over bid by any of the large global pharma companies out there.

It's going to be an interesting balance of 2023 imho.

<< Previous

Bullboard Posts

Next >>

Cybin launches new program phase to treat Major Depressive Disorder